|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 196.50 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.398000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 195.00 °F. TCC ( 90.60 °C. ) (est)
|
| logP (o/w): | 1.458 (est) |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-human TDLo 714 ug/kg VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION Archives of Internal Medicine. Vol. 39, Pg. 404, 1927.
oral-human TDLo 45 mg/kg BEHAVIORAL: ANOREXIA (HUMAN
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Klinische Wochenscrift. Vol. 17, Pg. 1580, 1938.
intraperitoneal-mouse LD50 146 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Russian Pharmacology and Toxicology Vol. 39, Pg. 209, 1976.
intravenous-mouse LD50 50 mg/kg Annales Pharmaceutiques Francaises. Vol. 9, Pg. 390, 1951.
oral-mouse LD50 400 mg/kg Journal of the American Chemical Society. Vol. 63, Pg. 602, 1941.
unreported-mouse LDLo 300 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 8, Pg. 126, 1916.
intravenous-rabbit LDLo 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 36, Pg. 363, 1929.
|
| Dermal Toxicity: |
subcutaneous-guinea pig LDLo 316 mg/kg SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: TREMOR Journal of Pharmacology and Experimental Therapeutics. Vol. 47, Pg. 339, 1933.
subcutaneous-guinea pig LDLo 325 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE Journal of Pharmacology and Experimental Therapeutics. Vol. 32, Pg. 121, 1927.
subcutaneous-mouse LD50 470 mg/kg Journal of Pharmacy and Pharmacology. Vol. 15, Pg. 472, 1963.
subcutaneous-rabbit LDLo 300 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Archives of Internal Medicine. Vol. 39, Pg. 404, 1927.
subcutaneous-rat LDLo 160 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 71, Pg. 62, 1941.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for phenethyl amine hydrochloride usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for phenethyl amine hydrochloride flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | benzeneethanamine hydrochloride | | | benzeneethanamine, hydrochloride | | | benzeneethanamine, hydrochloride (1:1) | | | phenethyl ammonium chloride | | 2- | phenethylamine hydrochloride | | | phenethylammonium chloride | | 2- | phenyl ethyl amine hydrochloride | | 1- | phenyl-2-aminoethane hydrochloride | | 2- | phenylethanamine hydrochloride | | 2- | phenylethanamine hydrochloride (1:1) | | 2- | phenylethanamine;hydrochloride | | 2- | phenylethanaminium chloride | | | phenylethylamine hydrochloride | | 2- | phenylethylamine hydrochloride | | 2- | phenylethylaminehydrochloride |
Articles:
|